Open AccessReversible Cerebral Vasoconstriction Syndrome in the Setting of COVID-19 and Pleomorphic Sarcoma
Author(s) -
Ehab Harahsheh,
David Gritsch,
Amir A. Mbonde,
Michael Apolinario,
Joseph M. Hoxworth,
Bart M. Demaerschalk
Publication year - 2021
Publication title -
the neurologist/the neurologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.43
H-Index - 60
eISSN - 2331-2637
pISSN - 1074-7931
DOI - 10.1097/nrl.0000000000000387
Subject(s) - medicine , headaches , reversible cerebral vasoconstriction syndrome , sarcoma , malignancy , angiosarcoma , pathology , radiology , cardiology , vasoconstriction , surgery
Reversible cerebral vasonstriction syndrome (RCVS) is an increasingly recognized clinical and radiologic syndrome. However, it has been rarely reported in the setting of the novel coronavirus disease-2019 (COVID-19) infection or sarcomatous tumors. RCVS might be the initial manifestations of COVID-19 infection or noncatecholamine producing masses including sarcoma.